General Information of DTT (ID: TTMHFRY)

DTT Name HIF-prolyl hydroxylase 1 (HPH-1) DTT Info
Gene Name EGLN2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Daprodustat DMRNGD2 Anaemia 3A90 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
FG-4592 DM4XSQ2 Anaemia 3A90 Phase 3 [2]
BAY-85-3934 DM7NHLC Anemia 3A00-3A9Z Phase 2 [3]
------------------------------------------------------------------------------------
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-(carboxymethylamino)-2-oxoacetic acid DMQ2SNL Discovery agent N.A. Investigative [4]
Pyridine-2,4-dicarboxylic acid DM4G8WX Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).
2 The latest advances in kidney diseases and related disorders. Drug News Perspect. 2007 Dec;20(10):647-54.
3 Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects. PLoS One. 2014 Nov 13;9(11):e111838.
4 Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone de... J Med Chem. 2010 Aug 12;53(15):5629-38.